
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
COX5b CRISPR/Cas9 KO Plasmid (h) | sc-405159 | 20 µg | $397.00 |
COX5B encodes cytochrome c oxidase subunit 5B (COX5b), a nuclear-encoded component of mitochondrial complex IV that supports electron transfer from cytochrome c to molecular oxygen and contributes to proton pumping across the inner mitochondrial membrane. By modulating oxidative phosphorylation efficiency, COX5b influences cellular ATP production, redox balance, and mitochondrial membrane potential, integrating with pathways that coordinate mitochondrial biogenesis and stress responses. Altered complex IV function and COX5B expression are frequently studied in contexts of mitochondrial dysfunction, including bioenergetic remodeling in neurodegeneration, cardiometabolic disorders, and tumor metabolism. COX5B is also used as a marker gene in investigations of respiratory chain assembly, reactive oxygen species signaling, and mitochondrial-nuclear cross-talk.
COX5b CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the COX5B gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the COX5B together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the COX5B open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish COX5b protein expression.
This CRISPR knockout system enables efficient generation of COX5B-deficient cell models for investigation of COX5b signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.